Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- Brown University
- Study ID
- NCT06974604
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Dexamethasone oral — DRUGDexamethasone 10 mL daily for days 1-5 for each of the first 3 cycles of therapy Datopotamab Deruxtecan 6.0 mg/kg IV on day 1 every 21 days
Study Details
TROPION-DM/BrUOG-431 is a prospective, , phase 2 trial with two non-comparative cohorts analyzed jointly for primary endpoint in adult patients with either (Cohort 1:) advanced/metastatic hormone-receptor positive (\[HR+\], estrogen receptor and/or progesterone receptor positive) breast cancer (BC), or advanced/metastatic triple negative breast cancer (TNBC) or (Cohort 2:) advanced/metastatic non-squamous non-small cell lung cancer (NSCLC). All patients will be treated with Datopotumab deruxtecan (Dato-DXd) at 6 mg/kg IV every 3 weeks until disease progression or unacceptable toxicity. Due to the risk of stomatitis, the investigational component of this trial will be to incorporate alcohol-free dexamethasone mouthwash, 10 mL 0.5 mg/5mL oral solution, days 1-5, swish and spit four times daily for the first 3 cycles.
Key Dates
- Start date
- Oct 22, 2025
- Status verified
- Oct 2025
- Primary completion
- May 31, 2027
- Completion
- May 31, 2029
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Dexamethasone 10mLProphylactic oral dexamethasone
Primary Outcome Measure
Lower the incidence of all stomatitis [ Time Frame: Approximately 9 weeks ]
Central Contacts
- Brown University Oncology Research Group (BrUOG)401-863-3000
- Stephanie Graff, MD401-444-5388
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rhode Island and the Miriam Hospitals (Brown University Health) | Providence | Rhode Island | 02903/02906 |
Find similar trials in Providence, RI
Related Studies
- Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer CellsRecruiting · Washington University School of Medicine · St Louis, Missouri
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung CancerRecruiting · University of Colorado, Denver · Aurora, Colorado
- Specimen Banking From Patients With Lung CancerRecruiting · University of Colorado, Denver · Aurora, Colorado